Large population studies consistently fail to show that isotretinoin, commonly known by its former brand name Accutane, causes depression at the group level. A 2023 meta-analysis pooling data from over 1.6 million participants found that fewer than 4% of isotretinoin users developed depression within a year of treatment, and that users were actually less likely to attempt suicide in the years following their course than nonusers.1PubMed Central. Risk of Suicide and Psychiatric Disorders Among Isotretinoin Users But that reassuring headline coexists with hundreds of individual case reports, plausible brain-chemistry pathways, and a long FDA warning history that keep the question alive.
What the Population-Level Evidence Shows
The strongest available evidence comes from studies that track large numbers of isotretinoin users over time and compare them either to their own pre-treatment baselines or to acne patients on other medications. The results are more favorable to isotretinoin than most people expect. The same 2023 meta-analysis in JAMA Dermatology found that the pooled one-year rates of completed suicide, suicide attempt, suicidal ideation, and self-harm were each below half a percent. The one-year rate of depression was roughly 4%, which sounds worrying in isolation but needs context: acne patients who never take isotretinoin also carry an elevated depression risk, as discussed below.2PubMed Central. Risk of Suicide and Psychiatric Disorders Among Isotretinoin Users
When researchers compared isotretinoin users to the same patients’ own unexposed periods, the signal for depression essentially vanished. A large Swedish record-linkage study found that the risk of newly diagnosed depression or psychosis during active isotretinoin use was no different from the risk during periods when the same patients were not on any acne medication. Acne patients taking oral antibiotics actually had a somewhat higher risk estimate for new depression diagnoses than those taking isotretinoin.3Archives of Dermatology. Isotretinoin Use and Risk of Depression, Psychotic Symptoms, Suicide, and Attempted Suicide
A separate systematic review and meta-analysis published in BMJ Open pooled risk estimates across studies and found no overall association between isotretinoin use and depressive disorders. There was an interesting split by study design, though: retrospective studies, which look backward through medical records, did show a modest increase in depression risk, while prospective studies, which follow patients forward from the start of treatment, did not.4PubMed Central. Use of isotretinoin and risk of depression in patients with acne: a systematic review and meta-analysis That discrepancy matters because retrospective data are more prone to reporting bias: patients who became depressed may be more likely to recall and report their isotretinoin use.
Some studies go further and suggest isotretinoin may improve mood overall. One cross-sectional analysis comparing acne patients on isotretinoin to those on oral antibiotics found that the isotretinoin group had significantly fewer depressive symptoms and less psychological distress.5PubMed. Differences in Depression and Distress Between Acne Patients on Isotretinoin vs Oral Antibiotics An older study from the late 1980s found significant reductions in anxiety and depression after successful isotretinoin treatment, especially in patients whose skin improved the most.6PubMed. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin
Why the Concern Will Not Go Away
If large studies are broadly reassuring, why does isotretinoin still carry a psychiatric warning? Several reasons keep the debate open.
First, individual case reports are hard to ignore. By the end of 2002, the FDA’s adverse event database held over 3,000 reports of psychiatric events associated with isotretinoin, including 173 reports of suicide.7SpringerLink (Am J Clin Dermatol). Isotretinoin use and subsequent depression and suicide: presenting the evidence A smaller surveillance dataset from New Zealand documented cases where patients who stopped the drug improved, then relapsed into depression when they started a second course, a pattern called rechallenge that is among the strongest signals that a drug, rather than coincidence, is responsible.8Medsafe. Acute Depression and Isotretinoin
Second, the group-level data and the case reports are not necessarily in conflict. A study of Finnish military conscripts taking isotretinoin found that average depression scores declined over the course of treatment, yet the authors noted that individual patients may have idiosyncratic mood reactions.9PubMed Central. Psychiatric and Developmental Effects of Isotretinoin (Retinoid) Treatment for Acne Vulgaris In other words, the drug might improve mood for most people by clearing their acne while simultaneously triggering depression in a small subset through a separate biological pathway. Large studies are designed to detect average effects across populations, and a rare reaction affecting, say, 1 in 500 patients would be invisible in most statistical analyses while still representing real harm to those individuals.
Third, at least one small prospective study found that depression scores measured by the Beck Depression Inventory actually increased in both male and female patients after a course of isotretinoin, even as their skin improved.10PubMed Central. The Effect of Isotretinoin (Roaccutane) Therapy on Depression and Quality of Life of Patients with Severe Acne That finding cuts against the simple narrative that the drug only makes people feel better by clearing their skin. But this was a small, single-center study, and it sits in tension with the larger body of evidence.
The Acne Problem Underneath
One of the biggest obstacles to answering this question cleanly is that severe acne itself is strongly linked to depression and anxiety. You cannot simply compare isotretinoin users to the general population and attribute any extra depression to the drug, because people prescribed isotretinoin start out with worse acne, and worse acne brings worse mental health regardless of treatment.
A meta-analysis of studies on acne and mental health found a significant positive correlation between acne severity and both depression and anxiety.11PubMed. Acne vulgaris and risk of depression and anxiety: A meta-analytic review A separate study drilling into that relationship found strong correlations between having acne and experiencing depression, anxiety, and stress, with female patients reporting significantly higher levels of all three.12PubMed Central. Understanding the impact of acne vulgaris and associated psychological distress on self-esteem and quality of life via regression modeling with CADI, DLQI, and WHOQoL
This creates a confound that is almost impossible to fully untangle. If you give isotretinoin to someone with severe cystic acne who is already depressed because of their skin, and their depression persists or worsens during treatment (which takes months to work), is that the drug or the disease? Researchers have tried to control for this by comparing isotretinoin patients to acne patients on other treatments, and as noted, those comparisons tend to favor isotretinoin. But no observational study can completely eliminate the possibility that the sickest patients, both dermatologically and psychologically, are the ones prescribed the strongest medication.
What the Lab and Animal Research Suggests
Even though population data are mostly reassuring, laboratory findings provide a plausible biological basis for why some individuals might experience mood changes. Isotretinoin is a retinoid, and retinoids interact with receptors on DNA that regulate the transcription of genes involved in several brain chemical systems, including those that produce dopamine, serotonin, and norepinephrine.13PubMed Central. Isotretinoin and neuropsychiatric side effects: Continued vigilance is needed
Cell culture experiments have shown that isotretinoin increases levels of the serotonin reuptake transporter and a particular serotonin receptor in ways that could reduce the amount of serotonin available at synapses, the exact pattern implicated in some forms of depression.14PubMed. 13-cis-Retinoic acid alters intracellular serotonin, increases 5-HT1A receptor, and serotonin reuptake transporter levels in vitro However, a small pilot study that measured serotonin and its metabolites directly in acne patients before and during isotretinoin treatment did not find significant changes, raising the possibility that the cell-culture effect does not translate neatly to humans at typical drug doses.15PubMed Central. The effects of isotretinoin on serotonin: a prospective pilot study on acne patients
Animal experiments paint a more concerning picture, though how well they map onto humans is debatable. Mice given isotretinoin at clinical-equivalent doses showed reduced cell growth in the hippocampus, suppressed formation of new brain cells, and impaired ability to learn spatial tasks.16PubMed Central. 13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice A more recent mouse study found that chronic isotretinoin administration caused visible damage to neurons in both the hippocampus and prefrontal cortex, including cell shrinkage and tissue vacuolization.17Translational Psychiatry. Chronic administration of isotretinoin induces depressive- and anxiety-like behaviors by altering the neuroactive ligand-receptor interaction pathway in adolescent mice
Brain imaging in humans has offered a partial bridge between the animal work and the clinical question. A small study using PET scans found that isotretinoin treatment, but not antibiotic treatment, was associated with a roughly 21% decrease in brain metabolism in the orbitofrontal cortex, a region involved in processing emotions and known to function abnormally in depression.18PubMed. Functional brain imaging alterations in acne patients treated with isotretinoin That is a striking finding, though the sample was small and the clinical significance of a metabolic decrease is not straightforward. Still, it is one of the few pieces of human neuroimaging evidence suggesting isotretinoin may do something measurable to brain function.
Does the Dose Matter
A common assumption is that higher doses might carry more psychiatric risk. The evidence does not support that in a straightforward way. A nationwide population-based cohort study from Taiwan compared patients taking lower doses of isotretinoin (20 mg per day or less) to those on higher doses and found no significantly increased risk of psychiatric disorders in either group.19PubMed. Risk of psychiatric disorders in patients taking isotretinoin: A nationwide, population-based, cohort study in Taiwan This is consistent with the idea that if isotretinoin does trigger mood changes in susceptible individuals, it may be more about individual vulnerability than about how many milligrams are involved.
Who Might Be at Higher Risk
Since population-level data suggest isotretinoin does not cause depression across the board while case reports clearly show some individuals are affected, the practical question is whether those vulnerable individuals can be identified in advance. Frustratingly, the answer right now is mostly no. No reliable genetic test or biomarker exists that can predict who will have a psychiatric reaction to isotretinoin.
What we do know is directional rather than definitive. People with a personal or family history of depression or other mood disorders are generally considered to be at elevated baseline risk, and many dermatologists will discuss this before prescribing. An Israeli military study found that isotretinoin users showed relatively increased use of mental health services compared to controls, which could reflect either a drug effect or the fact that people seeking treatment for severe acne already have higher mental health needs.20PubMed Central. Psychiatric and Developmental Effects of Isotretinoin (Retinoid) Treatment for Acne Vulgaris
Having a prior history of depression does not automatically disqualify you from taking isotretinoin. Many dermatologists prescribe it to patients with well-managed mood disorders, typically with closer monitoring and in coordination with a mental health provider. The decision usually involves weighing the severity of the acne, the failure of other treatments, and the psychological toll that untreated severe acne itself exacts.
Monitoring During Treatment
In the United States, the iPLEDGE program, which all isotretinoin prescribers and patients must enroll in, warns about the risk of depression and suicidal ideation. But notably, iPLEDGE does not require or recommend specific screening tools. Some dermatologists have argued this is a gap. Validated questionnaires like the Patient Health Questionnaire (PHQ-2 and PHQ-9) are short, easy to administer, and could be given at each monthly visit to detect mood changes early.21PubMed. Depression screening using health questionnaires in patients receiving oral isotretinoin for acne vulgaris Other researchers have echoed this call, advocating for integration of depression screening into the existing iPLEDGE infrastructure rather than relying solely on patients to self-report.22JAMA Dermatology. Psychiatric Adverse Events in Patients Taking Isotretinoin as Reported in a Food and Drug Administration Database From 1997 to 2017
A French pilot study tested an adolescent-specific depression rating scale during routine isotretinoin visits and found that the vast majority of dermatologists found it easy to use and said it made it easier to open conversations about depression risk with their young patients. Over 90% of the adolescent patients found the questionnaire acceptable.23Clinical and Experimental Dermatology. First use of the Adolescent Depression Rating Scale (ADRS) in the management of young people with severe acne treated with isotretinoin The barriers to routine screening appear to be logistical and institutional rather than practical or patient-related.
If you are starting isotretinoin, it is worth being proactive about this regardless of what your prescriber requires. Track your own mood, sleep, energy, and motivation over the course of treatment. The most commonly reported psychiatric symptoms in adverse-event databases include persistent sadness, irritability, loss of interest in usual activities, fatigue, and changes in sleep. If you notice a sustained downward shift in any of these that lasts more than a few days, bring it up with your dermatologist or a mental health professional sooner rather than later. In some reported cases, mood symptoms resolved when the drug was stopped and returned when it was restarted, suggesting that for those individuals, the fix was straightforward even if the mechanism was not.24Medsafe. Acute Depression and Isotretinoin
Why Study Design Makes This So Hard to Settle
The isotretinoin-depression question is one of those cases where the study design almost entirely determines the answer you get. Randomized controlled trials, the gold standard for establishing cause and effect, are essentially impossible here. You cannot ethically assign people with severe acne to take a placebo for five or six months when an effective treatment exists. So researchers are stuck with observational methods, and each type has its own blind spots.
Retrospective studies that look back through medical records tend to find a modest increase in depression risk, while prospective studies that follow patients forward from the start tend to find no increase or even an improvement.25PubMed Central. Use of isotretinoin and risk of depression in patients with acne: a systematic review and meta-analysis The retrospective studies may be picking up reporting bias, or they may be capturing real cases that prospective studies miss because patients who become severely depressed drop out before their follow-up visits. Neither interpretation can be confirmed without a study design that does not exist.
Meanwhile, the JAMA Dermatology meta-analysis found that isotretinoin users were less likely than nonusers to attempt suicide at two, three, and four years after treatment.26PubMed Central. Risk of Suicide and Psychiatric Disorders Among Isotretinoin Users That finding is hard to square with a drug that causes depression, but it has alternative explanations. Clearing up severe acne may remove a major source of distress, and the kind of people who successfully complete a course of isotretinoin (with monthly blood tests and, for women, mandatory pregnancy prevention) may simply be healthier, more engaged with the medical system, and more likely to receive treatment for other conditions, including depression. These kinds of selection effects haunt nearly every isotretinoin study.
How Isotretinoin Compares to Other Acne Treatments for Mood Risk
The comparison to other acne drugs is useful context that often gets lost. The Swedish study mentioned earlier found that acne patients taking oral antibiotics had risk estimates for depression and psychosis that were at least as high as those for isotretinoin users, and in some comparisons higher.27Archives of Dermatology. Isotretinoin Use and Risk of Depression, Psychotic Symptoms, Suicide, and Attempted Suicide The cross-sectional survey that directly compared the two treatment groups found isotretinoin patients had fewer depressive symptoms and less psychological distress.28PubMed. Differences in Depression and Distress Between Acne Patients on Isotretinoin vs Oral Antibiotics
This does not necessarily mean antibiotics are more depressing than isotretinoin. It may mean that patients on antibiotics have been dealing with their acne for longer without resolution, or that the psychological burden of ongoing moderate acne treated with antibiotics is comparable to the burden of severe acne treated with isotretinoin. Either way, it undercuts the narrative that isotretinoin stands alone as a uniquely mood-altering acne drug. The emotional weight of living with persistent, treatment-resistant acne is itself substantial, and any acne medication needs to be evaluated against that backdrop rather than against a hypothetical baseline of perfect emotional health.